Table 2. Results of the association between NEAT1 and clinicopathological parameters.
| Outcome | Studies (n) | OR (HR) | 95%CI | P Value | Model | Heterogeneity |
|---|---|---|---|---|---|---|
| Chi2, I2, P Value | ||||||
| Tumor size (>3 cm vs. ≤3 cm) | 3 | 2.51 | 1.27-4.99 | 0.009 | Random | 4.60, 57%, 0.10 |
| TNM stage (III+IV vs. I+II) | 5 | 4.17 | 2.42-7.18 | 0.00001 | Random | 8.46, 53%, 0.08 |
| Differentiation (poor vs. well + moderate) | 4 | 1.45 | 0.72-2.91 | 0.3 | Random | 11.97, 75%, 0.007 |
| Lymph node metastasis (Yes vs. No) | 5 | 1.39 | 0.54-3.60 | 0.5 | Random | 29.01, 86%, 0.0001 |
| Distant metastasis (M1 vs. M0) | 6 | 2.72 | 1.28-5.79 | 0.01 | Random | 17.75, 72%, 0.003 |
| Digestive system tumor | 7 | 1.54 | 1.37-1.73 | 0.00001 | Fixed | 6.98, 14%, 0.32 |
| Respiratory carcinomas | 3 | 1.44 | 1.11-1.85 | 0.005 | Fixed | 0.71, 0%, 0.70 |